A statistically significant worsening of DR in the group of patients using rhEPO compared to the non-receiving group was also noted, and a direct proportionality of the serum erythropoietin concentration and the deterioration of diabetic eye disease was determined [39, 40]. The gene discussed is EPO; the disease is diabetic eye disease.